Access cutting-edge pancreatitis, acute necrotizing treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Orlando location
Preparing your pre-screening questions…
Access pancreatitis, acute necrotizing specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatitis, acute necrotizing treatment provided free
Check if you qualify for this pancreatitis, acute necrotizing clinical trial in Orlando, FL
No-Cost Study Care
Local to Orlando
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Pancreatic necrosis complicates approximately 20-30% of severe acute pancreatitis cases. While many collections resolve without intervention, persistent symptomatic collections-particularly when infected-are associated with significant morbidity and mortality and frequently require procedural management. Current guidelines recommend delaying intervention until collections are fully walled off, typically around four weeks. However, in clinical practice, many patients deteriorate before this window is reached. Prospective data from our institution, supported by recent meta-analyses, suggest that early intervention using modern endoscopic techniques can be performed safely, even when undertaken within the first four weeks of disease onset. We believe that, in appropriately selected patients, early endoscopic intervention may prevent clinical deterioration, reduce complications, shorten hospital stay, and decrease overall healthcare utilization compared with a delayed approach. To formally evaluate this strategy, an international, multicenter randomized trial is being conducted, entitled Strategic Timing of Endoscopic Procedural Interventions in Infected Necrotizing Pancreatitis (STEP-IN Trial).
Sponsor: Orlando Health, Inc.
Yes, this clinical trial (NCT07406698) has an active research site in Orlando, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for pancreatitis, acute necrotizing treatment options in Orlando, FL, this clinical trial (NCT07406698) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatitis, acute necrotizing specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all pancreatitis, acute necrotizing clinical trials near you to find additional studies recruiting in your area.
See all pancreatitis clinical trials recruiting in Orlando — not just this study.
Browse Pancreatitis Trials in Orlando →